GLP-1 Weight Loss in New York (2026)
70 GLP-1 telehealth providers ship to New York, New York. Compounded semaglutide averages $229/month — same active ingredient as Wegovy and Ozempic, a fraction of the cost.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
About GLP-1 Access in New York
New York is largest city in the United States, located in New York with a population of approximately 8.3 million. Telehealth is legal in New York, and licensed GLP-1 providers can prescribe semaglutide or tirzepatide and ship directly to New York ZIP codes. Prices, formulary availability, and specific provider state coverage vary — confirm with the provider before starting.
New York's adult obesity rate is approximately 27.3% based on CDC Behavioral Risk Factor Surveillance System data[2], and state rankings are published in CDC's Adult Obesity Facts[3].
Browse by Medication
GLP-1 Providers Serving New York
Editorial score · methodology
Amazon One Medical
Best for: the most authoritative branded GLP-1 channel with same-day delivery and integrated manufacturer savings
Editorial score · methodology
Editorial score · methodology
Vytora Health
Best for: Patients seeking month-to-month or 3-month-bundle compounded semaglutide or tirzepatide with the option of brand-name Mounjaro/Zepbound on a single LegitScript-approved + HIPAA-compliant platform with named pharmacy partners and transparent operating-PC disclosure. Particularly suited for patients in KS, LA, MS, NM, WV where Vytora's audio-visit option satisfies state telehealth compliance.
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
LillyDirect Foundayo
Best for: patients with commercial insurance who want the cheapest legal brand-name GLP-1
Editorial score · methodology
Editorial score · methodology
Tyde Wellness
Best for: Cash-pay patients wanting transparent compounded-GLP-1 pricing with named, LegitScript-certified pharmacy fulfillment and the option to bundle menopause/HRT, hair loss, or longevity peptides through a single 50-state provider.
Editorial score · methodology
Elara Health and Wellness
Best for: Patients seeking a physician-guided bundled-care GLP-1 program (medication + quarterly labs + physician visits + coaching + 24/7 messaging at a single monthly price) with maximum pharmacy-partner transparency (four named 503A pharmacies disclosed) and clear corporate accountability (JTE Medical, LLC named parent). Strong fit for buyers who want more than transactional Rx access but don't need the unlimited-primary-care scope of true DPC models.
Editorial score · methodology
Fresh Day Meds
Best for: Price-sensitive patients seeking the lowest-cost compounded semaglutide or tirzepatide from a LegitScript-certified, HIPAA-compliant multi-product telehealth platform with publicly disclosed Texas corporate headquarters, who don't require a named pharmacy partner or brand-name GLP-1 fallback.
Editorial score · methodology
Editorial score · methodology
Calibrate Health
Best for: patients with insurance coverage who want a year-long coaching-wrap around branded Wegovy / Zepbound / Foundayo
Editorial score · methodology
NP2GO
Best for: Cost-sensitive patients in any of the 39 supported states + DC who want transparent per-dose pricing with the flexibility to choose Pay As You Go or Month-to-Month Membership. Particularly suited for Oklahoma residents who can access the in-person Edmond office + the additional Oklahoma-only services on one platform.
Editorial score · methodology
Curex
Best for: affordable compounded GLP-1 with strong corporate transparency and pharmacy testing
Editorial score · methodology
Editorial score · methodology
Precision Telemed
Best for: transparent month-to-month compounded GLP-1 with pharmacy quality documentation
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Gimme Care
Best for: affordable compounded GLP-1 with nationwide coverage and microdose options
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Nalena
Best for: Women seeking transparent low-entry-price ($149/mo) compounded semaglutide or tirzepatide on a GLP-1-only platform with no membership fees, no hidden costs, money-back guarantee, and free 2-day shipping. Not recommended for patients who require brand-name FDA-approved GLP-1s — Nalena is compounded-only.
Editorial score · methodology
Ondra Health
Best for: Cost-sensitive patients who want the lowest compounded-GLP-1 monthly cost and are willing to commit quarterly.
Editorial score · methodology
Editorial score · methodology
BetterMe Rx
Best for: patients who value pharmacy transparency — six named compounding partners
Editorial score · methodology
Editorial score · methodology
Maves (Homera Health)
Best for: Performance-oriented buyers (men's health + body optimization framing) seeking aggressive first-month pricing ($99/mo semaglutide intro) with a verifiable LegitScript ID, all-50-state coverage, and brand-plus-parent corporate disclosure (Maves under Homera Health). Strong fit for buyers who prioritize transparency signals (verifiable LegitScript ID + verbatim FDA disclaimer) over named pharmacy partners.
Editorial score · methodology
MEDVi
Best for: patients who want the option to switch between compounded and brand-name GLP-1 through one provider
Editorial score · methodology
NiceRx
Best for: patients seeking batch-tested compounded GLP-1 with transparent entity disclosure
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Mint Med
Best for: Cost-sensitive buyers seeking flat $159/mo 'all doses' compounded GLP-1 pricing without per-tier escalation, with HSA/FSA payment + no-membership pay-as-you-go model + LegitScript verification + verbatim FDA disclaimer. Strong fit for self-pay patients in any of the 36 listed states who value pricing transparency + cancel-anytime over premium clinical features.
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Vitara RX
Best for: Cost-sensitive patients seeking the lowest flat-rate compounded GLP-1 pricing from a LegitScript-certified marketplace with a named 503A pharmacy, who are comfortable with a marketplace model lacking a named medical director and a strict no-refunds policy.
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
PeterMD
Best for: men seeking flat-priced compounded GLP-1 access alongside TRT or peptide therapy
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Care Clinics
Best for: Cost-sensitive patients in one of the 32 listed states who want a LegitScript-certified telehealth clinic with multi-duration program options (from 4-week trials to 3-month commitments to extended plans) and a named PLLC corporate entity for accountability.
Editorial score · methodology
Editorial score · methodology
PlushCare
Best for: readers who want a primary-care relationship with GLP-1 prescribing as one option, AND who read the class-action disclosure and verify the cancellation flow before subscribing
Editorial score · methodology
Rewinding RX
Best for: Patients seeking a longevity / biological-age-reversal framing for their GLP-1 protocol (vs weight-loss-only positioning), who want MD-only clinical review (no PAs / NPs), LegitScript-verifiable certification, and flat-rate any-dose pricing — and who are comfortable signing up to see specific dollar amounts.
Editorial score · methodology
Get StartedRead full Rewinding RX review →Gatlan
Best for: Buyers seeking a named-clinical-leadership GLP-1 platform with Dr. Robert Lufkin (UCLA/USC) as Chief Medical Advisor, who value verifiable academic credentials over anonymous DTC marketplace framing, and who live in one of the 44 covered states. Strong fit for premium-clinical-attention buyers who are comfortable with pricing gated behind sign-up.
Editorial score · methodology
Get StartedRead full Gatlan review →InstaRX
Best for: Patients in any of the 50 states or DC seeking a multi-product compounded-medication telehealth platform (GLP-1 + peptides + sexual health) where they prefer to complete an intake to see pricing rather than comparing public per-dose tiers. NOT recommended for patients who require transparent upfront pricing, named pharmacy-partner disclosure, or visible LegitScript/HIPAA accreditation before committing to an intake.
Editorial score · methodology
Editorial score · methodology
Zealthy
Best for: not currently recommended — listed for transparency and reader awareness only
Editorial score · methodology
In-Person vs Telehealth in New York
Patients in New York have two main paths to GLP-1 treatment: an in-person obesity medicine or bariatric program, or a licensed telehealth provider that ships to New York addresses. In-person programs are generally preferable for patients with complex medical needs, those pursuing bariatric surgery, or patients whose insurance covers a brand-name anti-obesity GLP-1 and requires in-person documentation. Telehealth is generally preferable for patients seeking cash-pay compounded semaglutide or tirzepatide from a 503A compounding pharmacy[5]. Medicaid and commercial insurance coverage of anti-obesity GLP-1s in New York varies by plan[4].
Cost of GLP-1 Medications in New York
Brand-name Wegovy in New York typically costs $1,349/month without insurance, while Zepbound runs $1,086/month. Compounded semaglutide through telehealth providers averages $$229/month in New York, representing savings of more than $13,000 per year.
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Get New York Price Alerts
Be the first to know about new GLP-1 providers and price changes in New York.
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.CDC BRFSS — Adult Obesity Prevalence Maps by State (Behavioral Risk Factor Surveillance System)— Centers for Disease Control and Prevention.
- 3.CDC — State Obesity Rankings and Adult Obesity Facts— Centers for Disease Control and Prevention.
- 4.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 5.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.